Hla Class I B44 Is Associated With Sustained Response To Interferon + Ribavirin Therapy in Patients With Chronic Hepatitis C

Abstract

HLA class I B44 is related to a higher rate of SR in combination therapy but not in interferon monotherapy, whereas HLA class II, tumor necrosis factor-alpha -238A or -308A seem not to influence response to the antiviral therapy. These findings may be of value in therapy selection for hepatitis C-infected patients.